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Highlights
 A multi-centre trial QA programme incorporating adaptive radiotherapy 
plan selection has been developed.
 This novel trial QA approach has been validated by 71 RTTs from ten 
UK centres.
 This novel trial QA process increased RTTs’ confidence and resulted in 
appropriate adaptive radiotherapy plan selection on-trial.
11 Abstract
2
3 Background and Purpose: Hypofractionated bladder RT with or without image guided 
4 adaptive planning (HYBRID) is a multicentre clinical trial investigating “Plan of the Day” 
5 (PoD) adaptive radiotherapy for bladder cancer. To ensure correct PoD selection a pre-
6 accrual guidance and assessment module was developed as part of an image guided 
7 radiotherapy quality assurance (IGRT QA) credentialing programme. This study aimed to 
8 evaluate its feasibility and effectiveness across multiple recruiting centres.
9
10 Materials and Methods: Individuals from participating centres remotely accessed an image 
11 database in order to complete the PoD module.  An assessment score of ≥83% was required 
12 in order to receive QA approval.  A questionnaire was used to gather user feedback on the 
13 module. PoD decisions for the first patient at each recruiting centre were retrospectively 
14 reviewed for protocol adherence.
15
16 Results: 71 radiation therapists (RTTs) from 10 centres completed the PoD module. The 
17 median assessment score was 92% (Range:58-100%) with 79% of RTTs passing the 
18 assessment on first attempt. All questionnaire respondents reported that the PoD module 
19 prepared them for plan selection. In 51/60 of on-trial treatments reviewed, the PoD selected 
20 by the centre agreed with QA reviewers.
21
22 Conclusions: The PoD QA module was successfully implemented in a multicentre trial and 
23 enabled pre-accrual assessment of protocol understanding. This increased operator 
24 confidence and resulted in appropriate PoD selection on-trial.
25
26 Introduction
27
28 Image guided radiotherapy (IGRT) and adaptive RT are increasingly employed with modern 
29 external beam radiotherapy (RT) to ensure the accurate delivery of treatment.  When 
30 implementing new IGRT techniques it is critical to ensure that this is undertaken is a safe 
31 and effective manner. This is especially important in the clinical trial setting when the trial 
32 involves the introduction of novel image guidance techniques to a recruiting centre, for which 
33 there may not be a standard departmental procedure. Delivery of a rigorous quality 
34 assurance (QA) program of the IGRT component of these adaptive RT trials is essential to 
35 maintain patient safety and ensure integrity of the trial data [1]. 
36 An initial step is to collect sufficient documentation relating to the imaging technique and 
37 tolerances for setup correction used by each centre and ensure these meet both national 
238 recommendations and minimum trial specifications. Locally developed programmes, 
39 including anatomical site specific competency assessments, are reviewed as part of the QA 
40 process to ensure that Radiation Therapists/Therapeutic Radiographers (RTTs) correctly 
41 implement IGRT within the trial [1]. Ensuring the quality of these processes and training at 
42 multiple sites remains a challenge for trials quality assurance teams.
43 Hypofractionated bladder RT with or without image guided adaptive planning (HYBRID; 
44 CRUK/12/055), is a randomised clinical trial in bladder RT and is the first multicentre 
45 adaptive plan-of-the-day (PoD) trial undertaken in the United Kingdom [2]. The POD 
46 approach utilises volumetric image guidance with cone-beam computed tomography 
47 (CBCT) to select the most appropriate prepared plan for that patient on a daily basis 
48 and this is suggested to be one of the commonest adaptive methods in bladder 
49 radiotherapy [3-4]. Adaptive RT trials utilising a PoD concept present a significant 
50 challenge when designing a trial QA programme. The role of IGRT in these trials is extended 
51 beyond confirming accurate patient set-up to active treatment decision making through soft 
52 tissue evaluation, in order to choose an optimal plan which encompasses the treatment 
53 volume and minimises dose to organs at risk (OAR) [1].  Such trials are likely to have 
54 endpoints, which directly link to accuracy of plan selection, for example toxicity, hence 
55 prospective assessment of protocol compliance and individual staff member’s competency is 
56 a critical element of the trial QA. A suitable QA programme must be applicable for all 
57 participating centres and allow for multi-vendor delivery equipment.
58 Several single centre studies have reported on the training and assessment of RT staff for 
59 adaptive bladder PoD selection [5-8]. Whilst workshop based training has been utilised 
60 effectively for these studies it is not considered practical in a larger multi-centre trial setting. 
61 A multi-centre adaptive bladder trial undertaken by the Trans-Tasman Radiation Oncology 
62 Group, utilised a series of web-based e-learning modules to improve knowledge of anatomy, 
63 treatment imaging and protocol requirements [9]. This web based platform was well received 
64 and utilised by many RT staff however a need for pre-accrual practical IGRT experience was 
65 expressed by a number of centres [10]. 
66 Against this background, a pre-accrual guidance and assessment module for adaptive plan 
67 selection in bladder RT was developed as part of an IGRT QA credentialing programme for 
68 the HYBRID trial. This module utilised a novel approach by providing RTTs practical hands-
69 on experience selecting the PoD with bladder CBCT images prior to trial recruitment. The 
70 primary study aim was to evaluate the feasibility of implementing a pre-accrual PoD 
71 guidance and assessment module in a multi-vendor, multi-centre trial setting. A secondary 
72 aim was to analyse the effectiveness of the module with regard to improving operator 
73 knowledge and confidence when selecting the PoD for HYBRID.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 
374 Materials and methods
75
76 HYBRID is a phase II multicentre randomised trial which followed a single centre pilot study 
77 (APPLY). HYBRID recruited 65 patients across 10 participating RT centres and completed 
78 recruitment in August 2016 [2]. Trial participants were randomised between standard and 
79 adaptive RT treatment and received a dose of 36Gy delivered in six fractions over six weeks.  
80 Participants randomised to the standard arm had a single RT plan covering the PTV, which 
81 was expanded from the empty whole bladder CTV using a standard isotropic margin. For 
82 those randomised to the adaptive arm, three PTVs (small, medium and large) were 
83 generated from a single empty bladder CTV using anisotropic population based expansions 
84 [11]. Three plans were then produced to cover the varying PTV sizes. For all patients a 
85 CBCT was acquired before each RT treatment and for the adaptive arm the most 
86 appropriate plan chosen to cover the entire bladder volume and minimise dose to 
87 surrounding OAR. 
88
89 HYBRID QA Programme
90 The National Radiotherapy Trials Quality Assurance (RTTQA) group worked in collaboration 
91 with the HYBRID Trial Management Group to define the expectations of the treatment plan 
92 selection and develop an appropriate QA programme consisting of pre-accrual and during 
93 accrual components. Centres wishing to participate in HYBRID completed a facility 
94 questionnaire which captured their experience with volumetric bladder IGRT and a process 
95 document to detail the adaptive patient pathways within their own department.  Pre-accrual 
96 outlining and planning benchmark cases were also undertaken, which is standard practice 
97 for most RT trial QA programmes.
98 An IGRT credentialing programme was designed in order to prospectively assess RTT 
99 competency with PoD selection for HYBRID. This included a pre-accrual PoD guidance and 
100 assessment module, a centre visit for the first adaptive patient recruited from each centre 
101 and retrospective review of PoD decisions for all recruited patients.
102
103 PoD Guidance and Assessment Module
104 The objective was to provide a vendor specific PoD guidance and assessment package to 
105 be accessed remotely by RTTs geographically spread across the UK. Therefore, two vendor 
106 specific image databases were setup with five sets of anonymised patient data each 
107 consisting of one planning CT and 6 CBCT scans from the pilot study, APPLY [7]. A web 
108 based approach to viewing and registration of image data enabled individual rather than 
109 centre credentialing and gave RTTs pre-accrual hands on experience with selecting the 
110 appropriate PoD. A multi-disciplinary working party consisting of clinicians and RTTs was 
4111 established to choose the “expert consensus answers” for the guidance and assessment 
112 cases.
113 Three sets of data in the image databases were used as guidance cases with the 
114 appropriate PoD selection, rationale and screenshots provided in an accompanying 
115 guidance document (figure 1). RTTs were able to register and manipulate the planning CT 
116 with each of the CBCTs as they would do for treatment verifications, to build confidence in 
117 both the plan selection and protocol requirements. The remaining two sets of data in the 
118 image databases, one female and one male case were used for the PoD assessment.  
119 For the PoD assessment process, RTTs were asked to independently register the 12 CBCT 
120 images using the trial protocol, and adjust the image registration as necessary to include the 
121 bladder volume within the smallest possible PTV contour from the three available plans. The 
122 protocol specified the requirement for a 3mm internal margin to allow for intra-fraction 
123 bladder filling. PoD selections for each case were recorded and submitted to RTTQA for 
124 review. 
125 A minimum pass mark of ≥10/12 (83%) with the “expert consensus answers” was necessary 
126 in order to pass the pre-accrual PoD assessment. The minimum pass mark was selected 
127 based on the 80% pass mark suggested by McNair et al following the PoD training and 
128 assessment of staff members at a single centre [6]. Only those staff members who had 
129 successfully completed the assessment were approved to undertake plan selection for 
130 HYBRID. Recruiting centres were responsible for ensuring that individuals maintained their 
131 competency through involvement with, or retrospective review of any recruited patients.
132
133 Data Analysis
134 The individual assessment scores were reviewed and analysed with descriptive statistics. 
135 Median assessment scores for the female and male case was compared using Wilcoxon 
136 signed rank test. Assessment results were also analysed according to staff “Agenda for 
137 change” (AFC) UK banding systems with staff ranging from Band 5 (junior) to Band 8 
138 (management). The Kruskal-Wallis test was used to compare the assessment scores for 
139 each AFC band. 
140
141 Online Questionnaire
142 An online questionnaire was circulated to the IGRT RTTQA lead at each trial centres to 
143 obtain information regarding their experiences with the assessment and PoD selection. This 
144 questionnaire included questions on database accessibility, image quality, timings and PoD 
145 confidence (table 1). 
146
147
5148 Retrospective review for first patient recruited at each centre
149 In order to ensure accuracy of PoD selection on-trial, the planning CT data and all six weekly 
150 CBCT were collected from each centre for their first HYBRID patient. The CBCTs acquired 
151 for each patient were evaluated by three QA reviewers and a consensus PoD decided for 
152 each treatment fraction. The reviewers PoD decision was compared with the PoD selected 
153 by the centre and any discrepancies reported.
154
155 Results
156
157 Pre-accrual PoD assessment results
158 The PoD guidance and assessment module was completed by 71 RTTs from 10 recruiting 
159 centres. As specified in the trial protocol, the PoD selection required the smallest possible 
160 PTV contour from the three available plans to cover the bladder volume with a 3mm internal 
161 margin at each assessment case. The median assessment score for all individuals was 92% 
162 (Range:58-100%) with 56/71 (79%) RTTs achieving the required pass mark on first attempt 
163 at the assessment (figure 2).  The 15 (21%) individuals who did not pass on their first 
164 attempt were asked to repeat the same assessment after QA feedback was provided.  The 
165 feedback was customised to each of those 15 individuals with detailed guidance focusing on 
166 the knowledge of pelvic anatomy, PTV margin concepts used in the trial, and the trial 
167 protocol requirements on PoD plan selections. The required concordance was achieved by 
168 12/15 RTTs on their second attempt, with a median pass rate of 92%. The assessment was 
169 discussed via a webinar with the remaining individuals and they were subsequently QA 
170 approved during a RTTQA centre visit for their first patient recruited to HYBRID.
171 Figure 3 shows the agreement with the expert consensus answers for each of the 12 
172 assessment CBCT images (1-6 for the female assessment CBCT and 7-12 for the male 
173 assessment CBCT). Of the 852 total PoD selections, 751 (88%) answers agreed with the 
174 expert answer.  For the PoD selections which disagreed with the expert consensus answer, 
175 no more than one size away in PTV was chosen eg medium PTV was chosen when the 
176 small PTV was the correct PoD answer. For CBCT where the expert consensus answer was 
177 medium, smaller PTVs were selected  for 3% and 10% and larger PTVs were selected for 
178 14% and <1%  of female and male CBCTs respectively. Significantly different median scores 
179 (p<0.05) were attained for the male PoD assessment (median = 100%, range 50-100%) than 
180 for the female PoD assessment (median = 83%, range 33-100%). As shown in the figure 4 
181 box plot graph, when separating RTTs by staff grading, no significant difference in the 
182 median scores (p=0.51) were seen between junior (AFC Band 5 & 6), senior (AFC Band 7) 
183 and managerial (AFC Band 8) staff.
184
6185 Questionnaire results  
186 The online questionnaire was completed by all 10 recruiting centres (table 1). Users found 
187 the documentation provided to access the database was clear and easy to follow. Due to the 
188 level of IT security at recruiting centres, 6/9 centres encountered initial difficulties with 
189 remotely accessing the imaging databases, however all centres reported issues with access 
190 were resolved effectively and efficiently.  Image quality was reported to be of sufficient 
191 quality to confidently complete the PoD assessment by 9/10 centres, with 7/10 centres 
192 reporting the images to be a similar quality to the CBCT images generated locally. The POD 
193 guidance and assessment module was completed by the majority of centres is less than 2 
194 hours. 
195 All respondents reported the PoD guidance and assessment module prepared them for PoD 
196 selection within the trial. 5/8 centres felt the guidance cases provided good examples of PoD 
197 selection with 3/8 stating either there was not enough variation in PTV sizes across the 
198 guidance cases or that not enough information was provided regarding why certain PTVs 
199 were chosen. Despite this, 6/8 respondents thought the guidance cases increased their PoD 
200 selection confidence with the remaining 2/8 citing that they were already experienced in 
201 reviewing bladder patients and the guidance cases provided a good reminder of the protocol 
202 requirements. 
203
204 First recruited patient concordance results
205 The PoD decisions for the first HYBRID patient recruited at each of the 10 participating 
206 centres, giving a total of 60 treatment fractions, were retrospectively reviewed. For 51/60 
207 (85%) treatment fractions the PoD selected by the recruiting centre agreed with the 
208 consensus PoD decided by the QA reviewers. Of the remaining 9 treatment fractions, the 
209 PoD chosen by the recruiting centre was always larger than that chosen by the reviewers. It 
210 is suggested that there was a tendency for participating centres to be more cautious in their 
211 approach to PoD selection. There were no treatment fractions where the PoD decision 
212 varied by more than one PTV size between the QA reviewers and recruiting centre. 
213
214 Discussion
215
216 This study describes the implementation of remote access image databases for individual 
217 staff assessment in adaptive bladder RT plan selection as part of a multi-centre randomised 
218 trial QA programme. Whilst QA exercises such as the facility questionnaire, external 
219 reference dosimetry checks, and benchmark delineation and planning cases have been 
220 widely adopted by most international trials groups, QA of the IGRT and treatment verification 
221 component of a trial remains uncommon [12-13].  IGRT QA across multiple recruiting 
7222 centres as part of a clinical trial presents several challenges including accommodating 
223 different vendors’ equipment, different levels of staff experience and departmental protocols 
224 including features such as action thresholds [15].  
225 For single centre clinical trials workshop based training has proved successful however this 
226 is likely to be difficult to orchestrate in a multi-centre clinical trial setting [5-6]. Multicentre 
227 pre-accrual IGRT credentialing has been attempted by other international QA groups [14-
228 15]. Middleton et al undertook a series of IGRT credentialing site visits using a laptop with 
229 Varian offline review package to prospectively review the image matching of fiducial markers 
230 in prostate patients. Each centre had a junior and senior RTT complete 39 image 
231 registrations and then the match data was exported for analysis. The authors noted that the 
232 ultimate goal would be to achieve a vendor independent web based system allowing 
233 credentialing of all RTTs rather than only a subset in a larger clinical trial setting [15].
234 As part of the BOLART adaptive bladder trial IGRT credentialing was implemented using a 
235 web based e-learning programme and on-line plan selection using phantoms to assess 
236 adherence to protocol.  The BOLART programme, whilst being easy to use and significantly 
237 improving protocol knowledge provided limited practical experience for appropriate PoD 
238 selection [9].  The phantom studies do provide practical experience but do not easily 
239 demonstrate the image artefacts and bladder deformation caused by physiological changes 
240 in real patient cases, and the challenges of 3D image registration within vendor-specific 
241 systems [16].  
242 A novel process for pre-accrual QA assessment of RTT competency in PoD selection has 
243 been developed and implemented in HYBRID. The process considers vendor specific user 
244 requirements, incorporates the complexity of real patient CBCT images and allows 
245 geographically diverse remote access across the UK providing a time efficient approach for 
246 IGRT training and QA assessment. The PoD assessment results from multiple RTTs across 
247 several recruiting centres demonstrated similar results to locally implemented programmes 
248 [6]. A median pass mark of 92% was attained, with 79% of staff achieving the required pass 
249 mark on the first attempt. The questionnaire feedback confirmed the guidance and 
250 assessment increased confidence and prepared staff for PoD selection within the HYBRID 
251 trial. There was a good agreement reported between the PoD selected by centres and PoD 
252 chosen by QA reviewers for the first patient recruited from each site.
253 The grade and number of staff undertaking the plan selection assessment was determined 
254 by each individual centre. In our study the grade of a staff member did not affect the pass 
255 mark achieved in the assessment.  This shows that the PoD guidance and assessment 
256 module provided good comprehensive instructions and allowed each staff member, 
257 regardless of experience, to understand and implement the trial protocol. This finding is 
258 consistent with Middleton et al who reported uniform matching of fiducial markers across 
8259 recruiting centres regardless of experience of the observer (junior vs senior RTT) for QA 
260 accreditation for the 08.01 PROFIT trial [15].
261 Our study suggested that assessment scores were lower on average for the female PoD 
262 assessment CBCT than the male PoD assessment CBCT. Also of those answers that did 
263 not agree with the expert answer, the majority of incorrect answers were larger for the 
264 female assessment CBCT and smaller for the male assessment CBCT. It is acknowledged 
265 that as only a single male and female case was used within this assessment it is difficult to 
266 draw any conclusions from this. Female and male cases were selected for the assessment 
267 to reflect the difference in patient’s anatomy that would be encountered in the trial. 
268 The web-based PoD guidance and assessment module was not without limitations. In the 
269 online questionnaire staff commented that the guidance cases required a more in-depth 
270 explanation of isocentre corrections applied and why certain PoD decisions were made. The 
271 PoD guidance document has been updated accordingly for future RTT training. As this was 
272 the first web based assessment module of its kind undertaken by the RTTQA group, there 
273 were some initial issues with accessing the remote databases due to security restriction 
274 employed by individual recruiting centres’ IT departments. These issues were dealt with in a 
275 timely manner and future web based systems will need to take hospital IT security issues 
276 into consideration in the early conception phase.
277
278 Conclusion
279
280 The PoD pre-accrual guidance and assessment module was successfully implemented 
281 which enabled RTTs from HYBRID participating centres to access and utilise CBCT data 
282 using a vendor specific system.  It is suggested that the module increases operator 
283 knowledge and confidence when selecting the PoD within the clinical trial. This novel 
284 approach can be utilised in future clinical trials which require QA of PoD selection. 
285
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Figure 1. Screen shots illustrating female (top) and male (bottom) assessment cases  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	
Figure 2. A bar chart illustrating RTTs scores for first attempt at assessment 
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Figure 3. A bar chart summarising the agreement with expert answers for each assessment 
CBCT. CBCT 1-6 represent the female CBCT cases and 7-12 represent the male CBCT 
cases 
 
 
 
	
0%	10%	
20%	30%	
40%	50%	
60%	70%	
80%	90%	
100%	
1	 2	 3	 4	 5	 6	 7	 8	 9	 10	 11	 12	Ag
re
em
en
t	w
it
h	
Ex
pe
rt
	A
ns
w
es
		
Assessment	CBCT	
Figure 4. A boxplot graph describing the assessment scores per AFC band 
	
Table 1: Hybrid questionnaire completed by 10 recruiting centres 
 
Question  Answer Options            Answer  Replies  
Database Access   
Did you find that the instructions provided for 
accessing the database were easy to follow? 
Yes 
No 
10 
0 
Did you encounter any difficulties in accessing the 
database? 
Yes 
No 
Skipped Answer 
6 
3 
1 
Were any issues raised regarding access to the 
database resolved efficiently and effectively? 
Yes 
No 
10 
0 
Image Quality  
How did the image quality compare to what you are 
used to? 
Better 
Similar 
Worse 
0 
7 
3 
Did you think the image quality was sufficient to 
complete the plan of the day assessment? 
Yes 
No 
9 
1 
Timings  
Approximately how long did you spend working 
through the guidance example cases in total? 
0-30 Minutes 
30-60 Minutes 
 >60 Minutes 
Skipped Answer 
1 
5 
3 
1 
Approximately how long did it take you to complete 
the assessment? 
0-30 Minutes 
30-60 Minutes 
 >60 Minutes 
Skipped Answer 
0 
7 
2 
1 
PoD Confidence  
Do you feel that the guidance cases provided good 
examples of how to implement the protocol? 
Yes 
No 
Skipped Answer 
5 
3 
2 
Do you think that completing the guidance cases 
increased your confidence in plan selection? 
Yes 
No 
Skipped Answer 
6 
2 
2 
Do you feel that the guidance and assessment has 
prepared you for plan selection within the trial? 
Yes 
No 
Skipped Answer 
9 
0 
1 
 
	
